BioSpace News Archive

Altamira Therapeutics Ltd., a company dedicated to developing therapeutics that address important unmet medical needs, announced that its affiliate, Altamira Medica, has received the necessary approvals to initiate a clinical investigation of Bentrio™ in COVID-19 patients.

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today released a video to shareholders reiterating its operational and clinical progress for lead product candidate, Berubicin, and addressing recent share price activity.

Dr. Paul Gagne and the research team at Vascular Breakthroughs, LLC, and Vascular Care Connecticut have reached a key clinical development milestone in their participation in the DEXTERITY clinical trials with enrollment of their first patient.

Enzychem Lifesciences (KOSDAQ: 183490), a late-stage biotechnology company, announced today that the company has completed the final Clinical Study Report (CSR) for their Phase 2 study of EC-18 in Chemoradiation-induced Oral Mucositis (CRIOM)/.

BriOri BioTech, an emerging pre-clinical stage biotech company focused on developing a pipeline of opiate-free topical pain medications, announces its patent for “Topical Compositions Containing Rofecoxib (Vioxx) and Methods of Making and Using the Same” was issued on March 1, 2022.

C2Dx, a privately held medical device company, announced its acquisition of Hemostatix Medical Technologies LLC (Hemostatix) effective on January 1, 2022.

M&B Sciences Inc, a fast-growing African-American owned, technology-driven clinical research organization, announces the acquisition of Clara Health, a company dedicated to using technology to increase access to clinical trials.

Romark announced today that results of its Vanguard Co-V clinical trial of NT-300 (nitazoxanide extended-release tablets, 300 mg) for treatment of mild or moderate COVID-19 have been published in Lancet’s eClinicalMedicine.

Dr. Robert Shahverdyan, Head of Vascular Access Center at Asklepios Klinik Barmbek of Hamburg, Germany, in partnership with Dr. Dirk Hentschel, President-Elect of VASA and Interventional Nephrologist at Brigham and Women’s Hospital of Boston, MA, have recently published a retrospective analysis of 150 consecutive radiocephalic (forearm) fistula VasQ™ External Support procedures at Seminars in Dialysis.

ONWARD Medical N.V., the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, announces the start of enrollment in the LIFT Home Study.